Please ensure Javascript is enabled for purposes of website accessibility

Monday's Top News Headlines

By Motley Fool Staff – Mar 31, 2014 at 9:36AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here are today's top news stories from

Here are today's top news headlines from Check back throughout the day as this list is updated, and follow us on Twitter at TMFBreaking.

Stock Market Today: Another Marvel Hit and a Spike in Demand for Eggs

Today’s Top Biotech Stories: Curis, Amgen, and Novartis

Weekend Box Office: ‘Noah’ Rides to Top Spot; Schwarzenegger’s ‘Sabotage’ Flops

J&J Accepts $4 Billion Carlyle Offer for Diagnostics Unit

Dominion Files Registration Statement for Dominion Midstream Partners, LP Initial Public Offering

Why Halozyme Therapeutics Inc. Popped Today

Chicago Economy Growth Slows to 8-Month Low

Dow Jumps as Microsoft, Disney Score Blockbusters; Dovish Yellen Boosts Financials

Texas Business Grows for 11th Straight Month

Chevron, Polish Firm to Explore for Shale Gas

U.S. Farmers Planting Less Corn, More Soybeans

FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge

Why Nordion, Inc. Shares Soared Today

Marchionne: Fiat Chrysler Can Boost Output to 6 Million Vehicles a Year by 2018

Why MannKind Corporation Shares Cratered Today

N.Y. Attorney General Sues FedEx Over Cigarettes

Why Shares of UTi Worldwide Inc. Plunged Today

Dow Falls for the Quarter, But Don't Count 2014 Out Yet

ExxonMobil: Governments "Highly Unlikely" to Severely Restrict Fossil Fuels

GM Recalling 1.5 Million Vehicles for Steering Defect

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.